ジョージア州における肺疾患の臨床試験
ジョージア州内の拠点で、肺疾患に関する11件の研究が参加者を募集しています。
ジョージア州内の都市
公式研究テキスト（英語）
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- Winship Cancer Institute of Emory University, Atlanta
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT06765109A Study of COVID-19 Vaccine(s) in Children and Adults
- AGILE Clinical Research Trials, LLC, Atlanta
被験者募集中第3相健康なボランティア歓迎
5歳以上 · 全性別 · 2026/09/28更新 · NCT07798648A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- The Hope Clinic of Emory University, Decatur
- Javara - Privia Medical Group Georgia - Fayetteville, Fayetteville
- Coastal Heritage Clinical Research, Hinesville
- 他1件
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/25更新 · NCT06679140Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- University Cancer & Blood Center, LLC, Athens
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07489066A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Velocity Clinical Research, Savannah, Savannah
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07013474A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Cpcc-Research Llc, East Point
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/09/22更新 · NCT06977581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University Cancer & Blood Center, LLC, Athens
- Emory University School of Medicine- Grady Campus, Atlanta
- Winship Cancer Institute, Emory University, Atlanta
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581Cooperative Assessment of Late Effects for SCD Curative Therapies
- Emory University School of Medicine, Atlanta
被験者募集中観察研究
4歳〜65歳 · 全性別 · 2026/07/27更新 · NCT05153967A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- University Cancer and Blood Center, Athens
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/05/27更新 · NCT03093116A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Emory University Winship Cancer Institute, Atlanta
被験者募集中第2相
18歳以上 · 全性別 · 2025/12/15更新 · NCT06619561Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- Augusta University, Augusta
被験者募集中第3相
18歳以上 · 全性別 · 2024/07/12更新 · NCT02735707ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。